Advanced search
1 file | 1.56 MB Add to list

Serum anti-GM2 and anti-GalNAc-GD1a ganglioside IgG antibodies are biomarkers for immune-mediated polyneuropathies in cats

Author
Organization
Abstract
Recent work identified anti-GM2 and anti-GalNAc-GD1a IgG ganglioside antibodies as biomarkers in dogs clinically diagnosed with acute canine polyradiculoneuritis, in turn considered a canine equivalent of Guillain-Barre syndrome. This study aims to investigate the serum prevalence of similar antibodies in cats clinically diagnosed with immune-mediated polyneuropathies. The sera from 41 cats clinically diagnosed with immune-mediated polyneuropathies (IPN), 9 cats with other neurological or neuromuscular disorders (ONM) and 46 neurologically normal cats (CTRL) were examined for the presence of IgG antibodies against glycolipids GM1, GM2, GD1a, GD1b, GalNAc-GD1a, GA1, SGPG, LM1, galactocerebroside and sulphatide. A total of 29/41 IPN-cats had either anti-GM2 or anti-GalNAc-GD1a IgG antibodies, with 24/29 cats having both. Direct comparison of anti-GM2 (sensitivity: 70.7%; specificity: 78.2%) and anti-GalNAc-GD1a (sensitivity: 70.7%; specificity: 70.9%) antibodies narrowly showed anti-GM2 IgG antibodies to be the better marker for identifying IPN-cats when compared to the combined ONM and CTRL groups (P = .049). Anti-GA1 and/or anti-sulphatide IgG antibodies were ubiquitously present across all sample groups, whereas antibodies against GM1, GD1a, GD1b, SGPG, LM1 and galactocerebroside were overall only rarely observed. Anti-GM2 and anti-GalNAc-GD1a IgG antibodies may serve as serum biomarkers for immune-mediated polyneuropathies in cats, as previously observed in dogs and humans.
Keywords
GUILLAIN-BARRE-SYNDROME, DEMYELINATING POLYNEUROPATHY, PERIPHERAL NEUROPATHY, GALNAC-GD1A, ANTIGANGLIOSIDE, COMPLEMENT, NERVE, DOGS, GM2, (max 5), feline, auto-antibody, glycolipid, GM2, poly(radiculo)neuropathy

Downloads

  • published article.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 1.56 MB

Citation

Please use this url to cite or link to this publication:

MLA
Halstead, Susan K., et al. “Serum Anti-GM2 and Anti-GalNAc-GD1a Ganglioside IgG Antibodies Are Biomarkers for Immune-Mediated Polyneuropathies in Cats.” JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, vol. 28, no. 1, Wiley, 2023, pp. 32–40, doi:10.1111/jns.12529.
APA
Halstead, S. K., Jackson, M., Bianchi, E., Rupp, S., Granger, N., Menchetti, M., … Rupp, A. (2023). Serum anti-GM2 and anti-GalNAc-GD1a ganglioside IgG antibodies are biomarkers for immune-mediated polyneuropathies in cats. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 28(1), 32–40. https://doi.org/10.1111/jns.12529
Chicago author-date
Halstead, Susan K., Mark Jackson, Ezio Bianchi, Stefan Rupp, Nicolas Granger, Marika Menchetti, Greta Galli, et al. 2023. “Serum Anti-GM2 and Anti-GalNAc-GD1a Ganglioside IgG Antibodies Are Biomarkers for Immune-Mediated Polyneuropathies in Cats.” JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 28 (1): 32–40. https://doi.org/10.1111/jns.12529.
Chicago author-date (all authors)
Halstead, Susan K., Mark Jackson, Ezio Bianchi, Stefan Rupp, Nicolas Granger, Marika Menchetti, Greta Galli, Paul Freeman, Adriana Kaczmarska, Sofie Bhatti, Josep Brocal, Roberto Jose-Lopez, Andrea Tipold, Rodrigo Gutierrez Quintana, Edward J. Ives, Theofanis Liatis, Jasmin Nessler, Clare Rusbridge, Hugh J. Willison, and Angie Rupp. 2023. “Serum Anti-GM2 and Anti-GalNAc-GD1a Ganglioside IgG Antibodies Are Biomarkers for Immune-Mediated Polyneuropathies in Cats.” JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 28 (1): 32–40. doi:10.1111/jns.12529.
Vancouver
1.
Halstead SK, Jackson M, Bianchi E, Rupp S, Granger N, Menchetti M, et al. Serum anti-GM2 and anti-GalNAc-GD1a ganglioside IgG antibodies are biomarkers for immune-mediated polyneuropathies in cats. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2023;28(1):32–40.
IEEE
[1]
S. K. Halstead et al., “Serum anti-GM2 and anti-GalNAc-GD1a ganglioside IgG antibodies are biomarkers for immune-mediated polyneuropathies in cats,” JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, vol. 28, no. 1, pp. 32–40, 2023.
@article{01HJSASKRDKTFEW2281PZZBYN6,
  abstract     = {{Recent work identified anti-GM2 and anti-GalNAc-GD1a IgG ganglioside antibodies as biomarkers in dogs clinically diagnosed with acute canine polyradiculoneuritis, in turn considered a canine equivalent of Guillain-Barre syndrome. This study aims to investigate the serum prevalence of similar antibodies in cats clinically diagnosed with immune-mediated polyneuropathies. The sera from 41 cats clinically diagnosed with immune-mediated polyneuropathies (IPN), 9 cats with other neurological or neuromuscular disorders (ONM) and 46 neurologically normal cats (CTRL) were examined for the presence of IgG antibodies against glycolipids GM1, GM2, GD1a, GD1b, GalNAc-GD1a, GA1, SGPG, LM1, galactocerebroside and sulphatide. A total of 29/41 IPN-cats had either anti-GM2 or anti-GalNAc-GD1a IgG antibodies, with 24/29 cats having both. Direct comparison of anti-GM2 (sensitivity: 70.7%; specificity: 78.2%) and anti-GalNAc-GD1a (sensitivity: 70.7%; specificity: 70.9%) antibodies narrowly showed anti-GM2 IgG antibodies to be the better marker for identifying IPN-cats when compared to the combined ONM and CTRL groups (P = .049). Anti-GA1 and/or anti-sulphatide IgG antibodies were ubiquitously present across all sample groups, whereas antibodies against GM1, GD1a, GD1b, SGPG, LM1 and galactocerebroside were overall only rarely observed. Anti-GM2 and anti-GalNAc-GD1a IgG antibodies may serve as serum biomarkers for immune-mediated polyneuropathies in cats, as previously observed in dogs and humans.}},
  author       = {{Halstead, Susan K. and  Jackson, Mark and  Bianchi, Ezio and  Rupp, Stefan and  Granger, Nicolas and  Menchetti, Marika and  Galli, Greta and  Freeman, Paul and  Kaczmarska, Adriana and Bhatti, Sofie and  Brocal, Josep and  Jose-Lopez, Roberto and  Tipold, Andrea and  Gutierrez Quintana, Rodrigo and  Ives, Edward J. and Liatis, Theofanis and  Nessler, Jasmin and  Rusbridge, Clare and  Willison, Hugh J. and  Rupp, Angie}},
  issn         = {{1085-9489}},
  journal      = {{JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM}},
  keywords     = {{GUILLAIN-BARRE-SYNDROME,DEMYELINATING POLYNEUROPATHY,PERIPHERAL NEUROPATHY,GALNAC-GD1A,ANTIGANGLIOSIDE,COMPLEMENT,NERVE,DOGS,GM2,(max 5),feline,auto-antibody,glycolipid,GM2,poly(radiculo)neuropathy}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{32--40}},
  publisher    = {{Wiley}},
  title        = {{Serum anti-GM2 and anti-GalNAc-GD1a ganglioside IgG antibodies are biomarkers for immune-mediated polyneuropathies in cats}},
  url          = {{http://doi.org/10.1111/jns.12529}},
  volume       = {{28}},
  year         = {{2023}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: